Can Antiretroviral Drugs Be Used to Treat Porcine Endogenous Retrovirus (PERV) Infection after Xenotransplantation?

No PERV transmission during a clinical trial of pig islet cell transplantation

(2017) Vladimir A. Morozov et al.   VIRUS RESEARCH

Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice

(2016) Philip Lackey et al.   CLINICAL DRUG INVESTIGATION

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

(2016) Huldrych F. Günthard et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Past, Present, and Future Drug Delivery Systems for Antiretrovirals

(2016) Ameya R. Kirtane et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Susceptibility of porcine endogenous retrovirus to anti-retroviral inhibitors

(2016) Takele Argaw et al.   XENOTRANSPLANTATION

Porcine endogenous retrovirus-A/C: biochemical properties of its integrase and susceptibility to raltegravir

(2015) Antonin Demange et al.   JOURNAL OF GENERAL VIROLOGY

Cytotoxic Effects during Knock Out of Multiple Porcine Endogenous Retrovirus (PERV) Sequences in the Pig Genome by Zinc Finger Nucleases (ZFN)

(2015) Marwan Semaan et al.   PLoS One

Genome-wide inactivation of porcine endogenous retroviruses (PERVs)

(2015) L. Yang et al.   SCIENCE

Preventing transfer of infectious agents

(2015) Joachim Denner et al.   International Journal of Surgery

Porcine endogenous retrovirus infection of human peripheral blood mononuclear cells

(2014) Joachim Denner   XENOTRANSPLANTATION

Progress in pig-to-non-human primate transplantation models (1998-2013): a comprehensive review of the literature

(2014) David K. C. Cooper et al.   XENOTRANSPLANTATION

Microbiological safety of the first clinical pig islet xenotransplantation trial in New Zealand

(2014) Shaun Wynyard et al.   XENOTRANSPLANTATION

Novel neutralising antibodies targeting the N-terminal helical region of the transmembrane envelope protein p15E of the porcine endogenous retrovirus (PERV)

(2013) Alexander Waechter et al.   IMMUNOLOGIC RESEARCH

HIV-1 reverse transcriptase and antiviral drug resistance. Part 1

(2013) Kalyan Das et al.   Current Opinion in Virology

HIV-1 reverse transcriptase and antiviral drug resistance. Part 2

(2013) Kalyan Das et al.   Current Opinion in Virology

Infection Barriers to Successful Xenotransplantation Focusing on Porcine Endogenous Retroviruses

(2012) J. Denner et al.   CLINICAL MICROBIOLOGY REVIEWS

Increased titers of neutralizing antibodies after immunization with both envelope proteins of the porcine endogenous retroviruses (PERVs)

(2012) Joachim Denner et al.   Virology Journal

Long-term effects of PERV-specific RNA interference in transgenic pigs

(2012) Marwan Semaan et al.   XENOTRANSPLANTATION

Generation of neutralising antibodies against porcine endogenous retroviruses (PERVs)

(2011) Danny Kaulitz et al.   VIROLOGY

Inhibition of porcine endogenous retrovirus (PERV) replication by HIV-1 gene expression inhibitors

(2009) Minyi Shi et al.   ANTIVIRAL RESEARCH

Production of transgenic pigs that express porcine endogenous retrovirus small interfering RNAs

(2009) Jagdeece Ramsoondar et al.   XENOTRANSPLANTATION

Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors

(2008) Nicolas Sluis-Cremer et al.   VIRUS RESEARCH

Knockdown of porcine endogenous retrovirus (PERV) expression by PERV-specific shRNA in transgenic pigs

(2008) Britta Dieckhoff et al.   XENOTRANSPLANTATION